Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 029711/0363 | |
| Pages: | 6 |
| | Recorded: | 01/29/2013 | | |
Attorney Dkt #: | 18744-0022 |
Conveyance: | CORRECTIVE ASSIGNMENT TO CORRECT THE EVOTECH NEUROSCIENCES GMBH, ASSIGNOR AND EVOTECH INTERNATIONAL GMBH, ASSIGNEE NAMES PREVIOUSLY RECORDED ON REEL 029660 FRAME 0805. ASSIGNOR(S) HEREBY CONFIRMS THE EVOTEC NEUROSCIENCES GMBH, ASSIGNOR AND EVOTEC INTERNATIONAL GMBH, ASSIGNEE. |
|
Total properties:
4
|
|
Patent #:
|
|
Issue Dt:
|
05/01/2007
|
Application #:
|
10473696
|
Filing Dt:
|
09/29/2003
|
Publication #:
|
|
Pub Dt:
|
05/20/2004
| | | | |
Title:
|
PROTEIN DISULFIDE ISOMERASE AND ABC TRANSPORTER HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS
|
|
|
Patent #:
|
|
Issue Dt:
|
08/06/2013
|
Application #:
|
10564769
|
Filing Dt:
|
06/12/2006
|
Publication #:
|
|
Pub Dt:
|
06/24/2010
| | | | |
Title:
|
USE OF PLEITROPHIN FOR PREVENTING AND TREATING PANCREATIC DISEASES AND/OR OBESITY AND/OR METABOLIC SYNDROME
|
|
|
Patent #:
|
|
Issue Dt:
|
06/28/2011
|
Application #:
|
11913486
|
Filing Dt:
|
06/03/2008
|
Publication #:
|
|
Pub Dt:
|
11/20/2008
| | | | |
Title:
|
USE OF AZAPAULLONES FOR PREVENTING AND TREATING PANCREATIC AUTOIMMUNE DISORDERS
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
12437851
|
Filing Dt:
|
05/08/2009
|
Publication #:
|
|
Pub Dt:
|
12/03/2009
| | | | |
Title:
|
USE OF SECRETED PROTEIN PRODUCTS FOR PREVENTING AND TREATING PANCREATIC DISEASES AND/OR OBESITY AND/OR METABOLIC SYNDROME
|
|
Assignee
|
|
|
ESSENER BOGEN 7 |
HAMBURG, GERMANY 22419 |
|
Correspondence name and address
|
|
SUTHERLAND ASBILL & BRENNAN LLP
|
|
999 PEACHTREE STREE, NE
|
|
SUITE 2300
|
|
ATLANTA, GA 30309
|
Search Results as of:
06/14/2024 03:51 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|